Evidence map›Paper›PMID 41206790›Full record

ArticleChemSusChem2025

Molar-Scale Phenolic Acid Decarboxylation Using Thermostable Biocatalysts and Enzyme-Compatible Deep Eutectic Solvents.

Sonja Vaupel, Lars-Erik Meyer, Pablo Domínguez de María, Selin Kara

Abstract read
In one paragraph

Article in ChemSusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sonja VaupelInstitute of Technical Chemistry, Leibniz University Hannover, Callinstr. 5, 30167, Hannover, Germany.ORCID 0000-0003-3536-5774
Lars-Erik MeyerInstitute of Technical Chemistry, Leibniz University Hannover, Callinstr. 5, 30167, Hannover, Germany.ORCID 0000-0003-2591-0118
Pablo Domínguez de MaríaSustainable Momentum, SL., Av. Ansite 3, 4-6, Las Palmas de Gran Canaria, 35011, Canary Islands, Spain.ORCID 0000-0002-3117-7779
Selin KaraInstitute of Technical Chemistry, Leibniz University Hannover, Callinstr. 5, 30167, Hannover, Germany.ORCID 0000-0001-6754-2814

Funding

Marie Skłodowska-Curie 101072731
6 · The paper itself

Abstract

The synthesis of biogenic hydroxy styrenes by enzymatic decarboxylation of phenolic acids (e.g., ferulic, p-coumaric, caffeic, or sinapic acids) is a promising route involving biorefineries and biocatalysis, in which the low substrate solubility in water requires the quest for nonconventional media. This work explores the tunability of deep eutectic solvents (DES) to simultaneously create enzyme-compatible and solubilizing systems, in which thermostable phenolic acid decarboxylases (PAD) may operate at 50-70 °C, decreasing the inherent DES viscosity. Four DESs displaying high solubility of ferulic acid are assessed (with additions of up to 20 vol% of phosphate buffer): Choline chloride-glycerol (ChCl-Gly, 1:2), choline chloride-ethylene glycol (ChCl-EG, 1:2), choline acetate-glycerol (ChAc-Gly, 1:2), and betaine-glycerol (Bet-Gly, 1:2). Bet-Gly DES exerts promising properties, being a halide-free solvent, an enzyme-stabilizer at 50-70 °C (1.4 higher melting temperatures for the N31 ancestor Bacillus subtilis PAD), and 14-fold higher ferulic acid solubility compared to buffer. Intensified conditions of up to 1 M ferulic acid (≈200 g L

Indexed as

BiocatalysisCarboxy-LyasesDeep Eutectic SolventsHydroxybenzoatesTemperatureDecarboxylationEnzyme StabilitySolubilityCarboxy-LyasesDeep Eutectic SolventsHydroxybenzoatesphenolic acidphenolic acid decarboxylasedeep eutectic solventskineticsphenolic acid decarboxylasesprocess intensificationthermostability

Identifiers

PMID41206790
PMCPMC12703459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.